FDA Completes Inspection Of J&J Vaccine Maker Emergent BioSolutions, Cites Concerns Over Cross-Contamination, Sanitation
The U.S. Food and Drug Administration has completed its inspection of the Baltimore-based Johnson & Johnson vaccine maker Emergent BioSolutions Tuesday and “cited a number of observations concerning whether the facility’s processes met our requirements and standards.” The FDA has been inspecting the company’s Bayview facility after it was reported that due to “human error” …